Short answer: Willow sells compounded semaglutide for $299 a month all-in, and Hims sells FDA-approved GLP-1s from $298 a month all-in. For…
September 22, 2026
Aster Health digital care and obesity services
Quick verdict
- Best for
- patients in Aster DM Healthcare service areas seeking digital access to hospital-based obesity and bariatric care
- Key feature
- Digital access to Aster hospitals, clinics, pharmacies and clinical records, with obesity care delivered at participating facilities.
Aster Health is the digital access platform associated with Aster DM Healthcare in India, connecting patients with its hospitals, clinics, pharmacies, labs and home-care services. Obesity treatment is delivered through participating Aster facilities, including multidisciplinary clinics and bariatric services; the app is not a national GLP-1 subscription. Service availability, eligibility and costs depend on country, facility and clinician.
Our rating
Pros and cons
Pros
- App access is described for bookings, records and multiple services.
- Participating Aster facilities list multidisciplinary obesity and bariatric care.
- Hospital-based services can support in-person assessment and follow-up.
Cons
- There is no one network-wide price or standardized GLP-1 program.
- Availability and app features vary by location.
- Weight treatment is delivered at a particular hospital, not by a single direct-to-consumer telehealth pathway.
How it compares
Short answer: both mainly sell compounded GLP-1s, which are not FDA-approved. Mochi Health is cheaper at low doses, from $139 a month…
September 22, 2026
Short answer: Hims and Noom are different kinds of programs. Hims sells FDA-approved brand-name GLP-1s with a $149 membership, from $298 a…
September 22, 2026
User reviews
No user reviews yet.